Business News | Orbicular Announces Health Canada Approval for a G-Ozempic (Semaglutide Injection) in Partnership with Apotex | LatestLY
Get latest articles and stories on Business at LatestLY. New Delhi [India], May 4: Orbicular Pharmaceutical Technologies Pvt. Ltd., a specialty pharmaceutical company focused on complex generics and peptide-based therapeutics, today announced that a generic version of Ozempic (semaglutide injection), developed in partnership with Apotex, has received a Notice of Compliance (NOC) from Health Canada. The product will be marketed…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
 in Partnership with Apotex | LatestLY Get latest article){kind=link}